Luc Defebvre
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Luc Defebvre has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Alain Duhamel
Psyhub, CHU Lille, Lille, France
2 shared publications - Alexandre Kreisler
Department of Neurology and Movement Disorders, CHU Lille, F-59037 Lille, France
2 shared publications - Léa Mortain
Centre d’Etude et de Recherche en Informatique Médicale, EA 2694, Université de Lille, CHU Lille, F-59045 Lille, France
2 shared publications - Eugénie Mutez
Univ. Lille, Inserm, CHU Lille, U1172‐LilNCog‐Lille Neurosciences & Cognition Lille France
1 shared publication - K. Watel
CHU de Lille, Movement Disorders Department, 59000 Lille, France
1 shared publication - Kaëlig Watel
Department of Neurology and Movement Disorders, CHU Lille, F-59037 Lille, France
1 shared publication
Latest Publications
- Open Access
Doses of Botulinum Toxin in Cervical Dystonia: Does Ultrasound Guidance Change Injection Practices?
Background: Cervical dystonia is widely understood to benefit from botulinum toxin injections. The injection practices may be influenced by specific factors, including the method of injection. Three main guidance methods can be used: palpation of anatomical landmarks, ultrasound, and electromyography. We investigated how target muscles and doses of botulinum toxin were modified after the transition from surface anatomy (non-guided) to ultrasound (US-guided), in patients with cervical dystonia. We also determined the long-term dose trend. Methods: We studied a group of 82 patients, who received non-guided injections (median: 16.5 cycles/5.1 years) followed by US-guided injections (median: 12.0 cycles/3.8 years). Results: More muscles, and especially deep muscles, were injected during the US-guided period. The total dose and number of injected muscles were higher when US guidance was used, but the mean dose per muscle was lower. Over the long term, the total dose stabilized, and the mean dose per muscle decreased during the US-guided period. Conclusions: According to our results, the guidance method has a strong impact on the botulinum toxin injection strategy in cervical dystonia (target muscles and dose). Also, the treatment appeared more stable when using US guidance; this could be explained by the good precision of such injections.
Open AccessDoses of Botulinum Toxin in Cervical Dystonia: Does Ultrasound Guidance Change Injection Practices?
Background: Cervical dystonia is widely understood to benefit from botulinum toxin injections. The injection practices may be influenced by specific factors, including the method of injection. Three main guidance methods can be used: palpation of anatomical landmarks, ultrasound, and electromyography. We investigated how target muscles and doses of botulinum toxin were modified after the transition from surface anatomy (non-guided) to ultrasound (US-guided), in patients with cervical dystonia. We also determined the long-term dose trend. Methods: We studied a group of 82 patients, who received non-guided injections (median: 16.5 cycles/5.1 years) followed by US-guided injections (median: 12.0 cycles/3.8 years). Results: More muscles, and especially deep muscles, were injected during the US-guided period. The total dose and number of injected muscles were higher when US guidance was used, but the mean dose per muscle was lower. Over the long term, the total dose stabilized, and the mean dose per muscle decreased during the US-guided period. Conclusions: According to our results, the guidance method has a strong impact on the botulinum toxin injection strategy in cervical dystonia (target muscles and dose). Also, the treatment appeared more stable when using US guidance; this could be explained by the good precision of such injections.
- 8 February 2024
- Published by Elsevier in Revue Neurologique
- Vol. 180 (6) , 548-558
Does the guidance method affect the doses of botulinum toxin in writer's cramp?
- 8 February 2024
- Published by Elsevier in Revue Neurologique
- Vol. 180 (6) , 548-558
Does the guidance method affect the doses of botulinum toxin in writer's cramp?